English Overview
We are pleased to invite you for the next MBC TALKS webinar and
live Q&A session where Prof. Eva Ciruelos, Prof. Mark Thill and
Maria Noblet R.N. will discuss different CDK4&6i trials from an
endocrine resistance perspective with a focus on Abemaciclib and side
effects management.
This Activity for
- Resident / Fellow
- Physician
- Clinical Pharmacy
What I will learn?
- An overview of different CDK4&6i trials from an endocrine resistance perspective - 10 min
- Abemaciclib treatment, side effects management - 10 min
- Panel Discussion and live Q&A - 40 min
- Abemaciclib treatment, side effects management - 10 min
- Panel Discussion and live Q&A - 40 min
Additional items to the activity
| Optional Details | Type | Fee |
|---|---|---|
|
Optimizing CDK4&6 Inhibitor Treatment Outcomes Certificate
Certificate |
Certificate | Free |
VAT 15% Included
